Raghavendra S Patwardhan

Biochemistry — Bhabha Atomic Research Centre, India

LeadR Profile

Raghavendra S Patwardhan Bhabha Atomic Research Centre India
128 ScienceLeadR Reputation 128
Network Map

Biochemistry

Subspecialties: Pharmacy - Toxicology - Oncology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2009 - 2026

Source: PubMed

Bhabha Atomic Research Centre

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 43

Citations

Citations: 1 065 1st author: 14 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Spatiotemporal Redox Regulation of Cell-Cycle Progression: Dynamic Functions of Cellular Redox Regulatory Proteins.
cells, oxidants, antioxidants, thioredoxins, glutathione, cell cycle
Cells20260
Alr2204-Alr2205 form a functional modular thioredoxin system that enhances oxidative stress tolerance in cyanobacteria.
peroxiredoxins, stress, physiological, oxidative stress, cyanobacteria, thioredoxins, thioredoxin-disulfide reductase
Biochem J20260
Cold Atmospheric Plasma as an Immunomodulator: Suppression of T-cell Hyperactivation and Graft-versus-Host Disease via Redox Regulation.
cells, acetylcysteine, cold temperature, leukocytes, graft vs host disease, transplants, therapeutics, t-lymphocytes, plasma
J Leukoc Biol20260
First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent.
sars-cov-2, safety, chlorophyll, covid-19, pharmacology, peptide hydrolases, plants, medicinal, therapeutics, herbal medicine, antiviral agents, pharmacokinetics
Phytomedicine20250
p38 MAPK-mediated suppression of Nrf2-MPC2 axis drives metabolic reprogramming which confers imatinib resistance in blast crisis phase of chronic myeloid leukemia.
cells, pharmaceutical preparations, p38 mitogen-activated protein kinases, leukemia, cell biology, cell line, leukemia, myeloid, blast crisis, leukemia, myelogenous, chronic, bcr-abl positive
Exp Cell Res20251

LeadR Networks

Main global connection map